Novo Nordisk CEO set to defend Ozempic, Wegovy prices on Capitol Hill 

The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish pharmaceutical giant’s blockbuster drugs Ozempic and Wegovy.
Article Attribution | Read More at Article Source
The post Novo Nordisk CEO set to defend Ozempic, Wegovy prices on Capitol Hill  appeared first on RocketNews.